Similar Posts
The Prison as Laboratory_2002
"The voluntary consent of the human subject is absolutely essential," reads the Nuremberg Code of 1947, which was drafted in direct response to the sheer barbarity of Nazi-era medical experiments on Jews and other captive groups.
- AHRP Speaks Out | Informed Consent Waivers | NIH -- Ethics Violations | Unethical Experiments | Vulnerable Groups
AHRP Letter to Editor re: ARDS published NEJM
AHRP Letter to Editor re: ARDS published NEJM Fri, 11 Jul 2003 A truncated version of a Letter to the editor submitted by John H. Noble, Jr., PhD and Vera Sharav appears in the current July 10, 2003, issue of The New England Journal of Medicine. Note: On April 3,…
Non-Consensual Medical Experiments Expose Patients to Risk of Death
When invited to become subjects in a medical experiment, most African-Americans decline; the memory of Tuskegee is indelibly ingrained in their communal memory. Their distrust is buttressed by the evidence; before and since Tuskegee. This community has been subjected to a continuum pattern of discrimination and exploitation by the medical…
Doctors Deceived, Premature Infants’ Lives Sacrificed
Extremely low weight premature infants have an approximately 20% mortality rate — if treated with the best current practice. These babies’ lives are at serious risk. . . .
AHRP Files Federal Complaint Re: Non-Consensual “Blood Substitute” Experiment on Trauma Patients
This controversial, commercial experiment is being conducted without informed consent in trauma patients who require blood to survive. PolyHeme is being tested in patients in ambulances and at hospital emergency facilities where these trauma patients are denied life-saving real blood.
FDA Internal Document: Use of Placebo-Controls in Life Threatening Diseases
The efficacy and safety of a new drug that treats a serious and life threatening illness in premature infants will be studied versus sham/placebo in Latin America. The sponsor plans to apply for FDA approval, in addition to local and European registration. There are approved therapies (surfactants) for this illness (Respiratory Distress Syndrome, or RDS) in those countries where this trial is proposed to take place, and surfactants are even used in some of their hospitals. However, surfactants are completely unavailable to infants at many other hospitals, secondary to rationing or economic limitations.
